[1]
Mahalapbutr, P.; Sangkhawasi, M.; Kammarabutr, J.; Chamni, S.; Rungrotmongkol, T. Rosmarinic acid as a potent influenza neuraminidase inhibitor: in vitro and in silico study. Curr. Top. Med. Chem., 2020, 20(23), 2046-2055.
[2]
Ozturk, O.; Aki-Yalcin, E.; Yalcin, I.; Grifitth, R. Insight into mechanism of action of anticancer benzazoles. Curr. Top. Med. Chem., 2020, 20(23), 2056-2069.
[3]
Ravi, S.; Barui, S.; Kirubakaran, S.; Duhan, P.; Bhowmik, K. Synthesis and characterization of quinoline-3-carboxamide derivatives as inhibitors of the atm kinase. Curr. Top. Med. Chem., 2020, 20(23), 2070-2079.
[4]
Natarajan, N.; Thiruvenkatam, V. An insight of scientific developments in tsc for better therapeutic strategy. Curr. Top. Med. Chem., 2020, 20(23), 2080-2093.
[5]
Krátký, M.; Jaklová, K.; Štěpánková, Š.; Svrčková, K.; Pflégr, V.; Vinšová, J. N -[3,5-bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide analog-ues: novel acetyl- and butyrylcholinesterase inhibitors. Curr. Top. Med. Chem., 2020, 20(23), 2094-2105.
[6]
Krátký, M.; Štěpánková, Š.; Brablíková, M.; Svrčková, K.; Švarcová, M.; Vinšová, J. Novel iodinated hydrazide-hydrazones and their analogues as acetyl- and butyrylcholinesterase inhibitors. Curr. Top. Med. Chem., 2020, 20(23), 2106-2117.
